EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 23 srpnja 2024. Database contains 4691 unique substances/entries.
Filter the list

-
-
F Fungi
-
-
P Parasites
-
-
P Parasites
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
F Fungi
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
SUBSTANCE S171393
427-390-9
-
Skin Sens. 1
INDULIN MQK-1M
413-770-1
-
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
-
-
Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
F Fungi
-
-
F Fungi
-
-
P Parasites
-
-
P Parasites
-
-
P Parasites
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1
-
-
P Parasites
-
-
P Parasites
PRODUKT 1096
414-230-8
-
Skin Sens. 1
YELLOW JB 1238
423-110-4
-
Eye Dam. 1
-
-
P Parasites
-
-
Carc. 1B
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
P Parasites
-
-
P Parasites
-
-
P Parasites
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
F Fungi
-
-
F Fungi
-
-
P Parasites
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
F Fungi
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
show/hide
Isooctyl (2,4-dichlorophenoxy)acetate EC / List no: 246-704-3 | CAS no: 25168-26-7
Tetrahydrofurfuryl 2,4-dichlorophenoxyacetate EC / List no: 239-207-8 | CAS no: 15146-99-3
4-hydroxybutyl (2,4-dichlorophenoxy)acetate EC / List no: 252-929-8 | CAS no: 36227-43-7
Acetic acid, (2,4-dichlorophenoxy)-, dodecyl ester EC / List no: - | CAS no: 62855-71-4
Ethyl 2,4-dichlorophenoxyacetate EC / List no: 208-558-9 | CAS no: 533-23-3
Isopropyl 2,4-dichlorophenoxyacetate EC / List no: 202-305-6 | CAS no: 94-11-1
Nonyl (2,4-dichlorophenoxy)acetate EC / List no: 259-722-1 | CAS no: 55617-55-5
Octyl (2,4-dichlorophenoxy)acetate EC / List no: 217-674-9 | CAS no: 1928-44-5
2,4-D sec-butyl ester EC / List no: - | CAS no: 94-79-1
Butyl 2,4-dichlorophenoxyacetate EC / List no: 202-364-8 | CAS no: 94-80-4
2-butoxyethyl 2,4-dichlorophenoxyacetate EC / List no: 217-680-1 | CAS no: 1929-73-3
Acetic acid, (2,4-dichlorophenoxy)-, 2-propenyl ester EC / List no: - | CAS no: 58965-05-2
Heptyl 2,4-dichlorophenoxyacetate EC / List no: 217-634-0 | CAS no: 1917-96-0
Hexyl 2,4-dichlorophenoxyacetate EC / List no: 217-633-5 | CAS no: 1917-95-9
Isobutyl 2,4-dichlorophenoxyacetate EC / List no: 216-992-5 | CAS no: 1713-15-1
Acetic acid, (2,4-dichlorophenoxy)-, 4-pentylphenyl ester EC / List no: - | CAS no: 53640-17-8
Propyl 2,4-dichlorophenoxyacetate EC / List no: 217-677-5 | CAS no: 1928-61-6
Acetic acid, (2,4-dichlorophenoxy)-, 2-hydroxyethyl ester EC / List no: - | CAS no: 38383-43-6
Acetic acid, (2,4-dichlorophenoxy)-, vinyl ester EC / List no: - | CAS no: 4280-66-4
Methyl 2,4-dichlorophenoxyacetate EC / List no: 217-670-7 | CAS no: 1928-38-7
2,4-D crotyl ester EC / List no: - | CAS no: 14600-07-8
1,3-dimethylbutyl 2-(2,4-dichlorophenoxy)acetate EC / List no: 300-531-0 | CAS no: 93941-81-2
2,4-D, 2-octyl ester EC / List no: - | CAS no: 1917-97-1
2,4-D 3-butoxypropyl ester EC / List no: - | CAS no: 1928-45-6
(2,4-Dichlorophenoxy)acetic acid 2-butoxy-2-oxoethyl ester EC / List no: - | CAS no: 52671-26-8
Trimethylsilyl (2,4-dichlorophenoxy)acetate EC / List no: - | CAS no: 34113-76-3
2-Butoxypropyl (2,4-dichlorophenoxy)acetate EC / List no: - | CAS no: 10463-14-6
Nitrilotri-2,1-ethanediyl tris[(2,4-dichlorophenoxy)acetate] EC / List no: 299-308-8 | CAS no: 93858-74-3
Pentyl (2,4-dichlorophenoxy)acetate EC / List no: 217-631-4 | CAS no: 1917-92-6
2-ethylhexyl 2,4-dichlorophenoxyacetate EC / List no: 217-673-3 | CAS no: 1928-43-4
1-butoxypropan-2-yl 2-(2,4-dichlorophenoxy)acetate EC / List no: - | CAS no: 3966-11-8
-
-
Acute Tox. 4; Skin Sens. 1
-
-
Acute Tox. 4; Skin Sens. 1
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
P Parasites
-
-
P Parasites
-
-
P Parasites
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
Acute Tox. 2
-
-
Acute Tox. 4
-
-
F Fungi
-
-
F Fungi
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
P Parasites
-
-
Carc. 2
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
B Bacteria and similar species
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
show/hide
Chloroplatinic acid hexahydrate EC / List no: 629-612-1 | CAS no: 18497-13-7
Bis(benzyltrimethylammonium) hexachloroplatinate(2-) EC / List no: 255-585-7 | CAS no: 41909-89-1
Hexachloroplatinic acid EC / List no: 241-010-7 | CAS no: 16941-12-1
Dipotassium hexachloroplatinate EC / List no: 240-979-3 | CAS no: 16921-30-5
Disodium hexachloroplatinate EC / List no: 240-983-5 | CAS no: 16923-58-3
Diammonium hexachloroplatinate EC / List no: 240-973-0 | CAS no: 16919-58-7
Dicesium hexachloroplatinate EC / List no: 240-945-8 | CAS no: 16902-25-3
Hexachloroplatinate(2-) EC / List no: - | CAS no: 16871-54-8
Sodium hexachloroplatinate(IV) hexahydrate EC / List no: 626-326-9 | CAS no: 19583-77-8
-
-
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
AMINAZA TOLFAMATATE
418-350-1
-
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
-
-
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3

Export search results to: